Morrisville-based TrialCard lands Canary Insights — 5th acquisition in less than 2 years
Date Published:MORRISVILLE — TrialCard, a Morrisville-based healthcare company, has acquired Canary Insights, a Lakewood, Colorado-based healthcare information management company.
That adds to its portfolio a subscription service for identifying and tracking changes to health plan policy and coverage information.
TrialCard said this acquisition further strengthens its position as “a leading provider of payer intelligence for the biopharmaceutical and medtech industries.”
“For over twenty years, TrialCard has excelled at simplifying patient access to life-changing products,” said TrialCard President and CEO Mark Bouck, in a statement. “The acquisition of Canary Insights further enhances our ability to provide our clients with increased visibility into vital health plan policy information specific to their products.”
Today’s announcement also marks the fifth acquisition for TrialCard in the past two years.
In November 2019, TrialCard acquired Bellingham, Washington-based Policy Reporter, a healthcare technology company that also specializes in the monitoring and reporting of health plan policy intelligence.
TrialCard said it plans to combine Canary Insights’ expertise within the medical device and diagnostics marketplace with Policy Reporter’s patented policy monitoring technology to accelerate growth within both businesses.
Other acquisitions include TC Script, a non-commercial dispensing pharmacy licensed in all U.S. states and territories (October 2018); and Raleigh-based patient affordability competitor Rx Solutions (January 2019); and Mango Health, the leading provider of mobile-based medication and adherence solutions for the life sciences sector (September 2019).
Founded in 2000, TrialCard provides patient affordability, medication access and adherence, patient support, and clinical trial services on behalf of biopharmaceutical manufacturers.
It said it has connected over 33 million patients with nearly $15 billion in branded drug savings to date.
Original Article Source: WRAL TechWire